Mass General Brigham

Mass General Brigham hospitals and clinics are open and seeing patients. All scheduled appointments and procedures will happen as planned on Monday, July 22. _______________________ 𝐔𝐩𝐝𝐚𝐭𝐞: 𝐉𝐮𝐥𝐲 𝟏𝟗 - 𝟏𝟎:𝟑𝟐 𝐩.𝐦. Mass General Brigham mobilized incident command and other leadership teams across the organization to manage our response to the CrowdStrike incident. We have deployed hundreds of technicians to our hospitals, healthcare centers, and outpatient clinics to restore access to the systems and devices that were impacted by the software failure early this morning. We are doing everything possible to restore the electronic systems that support our patient care delivery across our system. Our teams will continue to work throughout the night to implement solutions and, at this time, we expect to be operational tomorrow. We apologize for the inconvenience that this has caused to the many patients who had scheduled visits with us today. _______________________ A major worldwide software outage has affected many of our systems at Mass General Brigham, as well as many major businesses across the country. Due to the severity of this issue, all previously scheduled non-urgent surgeries, procedures, and medical visits are cancelled today. Mass General Brigham remains open to provide care to patients with urgent health concerns in our clinics and emergency departments, and we continue to care for all patients currently receiving care in our hospitals. We have dedicated every available resource to resolve this issue as quickly as possible, and we apologize for the inconvenience this has caused our patients. It is our highest priority to ensure that our patients receive the safest care possible.

Mass General Brigham experts made an exciting discovery in a new study that found that carrying one copy of the APOE3 Christchurch genetic variant can delay early-onset Alzheimer's disease by five years. This breakthrough could pave the way for new therapeutic targets. http://spklr.io/6049SfZb

Stay updated on the latest in cancer treatment with our comprehensive clinical review of advances in immuno-oncology. Learn about molecularly-targeted therapies and immune system mobilization. Plus, join our optional session on managing immunotherapy toxicities, "Sink or Swim," for an in-depth look at common and uncommon toxicities. Register now: http://spklr.io/6042Shrj. #CancerTreatment #ImmunoOncology #MedicalEducation

The Mass General Brigham Disability Employee Inclusion Alliance (DEIA) and Community Care Van team celebrated ADA Day last week at Boston’s City Hall Plaza with Mayor Michelle Wu. The day commemorates the 34th anniversary of the Americans with Disabilities Act. The DEIA team spoke with visitors, providing links and information about careers at Mass General Brigham and sharing details about the Massachusetts General Hospital Lurie Center ASPIRE program including vocational preparation resources for people with autism. They distributed injury cold packs and hand sanitizer, and, given the abundance of sunshine, visitors were also grateful to receive sunscreen and sunglasses. Our Community Care Van team attended to 17 people over the two hours, offering care for blood pressure and diabetes, along with social risk mitigation. “Many people who stopped by our table told us how happy they were with the care they received at Mass General Brigham and appreciated being able to visit the care van,” said Zary Amirhosseini, manager of the Mass General disability program at the Office of Belonging and Engagement, co-chair of Disability Employee Inclusion Alliance ERG, and member of Mayor Wu’s Disability Advisory Board. “It was a great day with many organizations engaging with the community to share programs and activities that provide improved access and services for citizens with disabilities,” said Lynne Brady Wagner, Mass General Brigham health equity director, specialty hospitals and ERAP services lines, enterprise disability clinical equity lead. “We were proud to represent Mass General Brigham and look forward to returning to this annual celebration honoring the rights of people with disabilities.”

At Mass General Brigham we honor and support our veterans every day. Our veterans bring unparalleled skills, dedication, and a unique perspective to our team, and we are proud to have them as part of our family. Are you a veteran looking for a new career opportunity? We have a range of positions open and are eager to welcome more veterans into our ranks. Your experience, leadership, and resilience are exactly what we need to continue providing the best care to our community. Visit our website and apply today. http://spklr.io/6044ShRg #NationalHireAVeteranDay

The Mass General Brigham community was deeply saddened to learn of the passing of Jack Connors Jr., a visionary leader and Mass General Brigham founding Board Chair. Jack served as chair of the Brigham and Women's Hospital Board of Trustees from 1992 to 1996, when he was invited to serve as the chair of the Mass General Brigham board—a role he held for 16 years before becoming chair emeritus in 2012. He was incredibly generous and thoughtful with his time, talents and resources. Anne Klibanski, MD, president and chief executive officer of Mass General Brigham, reflects on his legacy. Learn more about Jack’s extraordinary life and contributions to our hospitals: https://bit.ly/3Sk3dLH

Mass General Brigham's new rapid genotyping test cuts brain tumor diagnosis time from 10 days to 2, avoiding invasive biopsies. It accurately identified tumors in 42% of cases with zero false positives. Learn how this collaboration is improving patient care. http://spklr.io/6048Ssag

Curious about what it takes to be a Medical Laboratory Science student at Mass General Brigham? Here's a glimpse into the qualities and skills that define our future laboratory scientists. Our program trains future laboratory scientists through a rigorous and integrated curriculum, combining hands-on didactic instruction, on-site clinical experiences, and online learning. With National Accrediting Agency for Clinical Laboratory Sciences (NAACLS) accreditation, we ensure that our graduates are well-prepared to excel in the dynamic field of laboratory medicine. Are you ready to join this journey? Learn more and become a part of the future of healthcare! http://spklr.io/6045SqSH

A new AI-driven study reveals key indicators of lung cancer outcomes. Learn more with lead author, Tafadzwa Chaunzwa, MD, and senior author Hugo Aerts, PhD, from Mass General Brigham's Artificial Intelligence in Medicine (AIM) Program. http://spklr.io/6049SWVl

Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program, and Bryan Choi, MD, PhD, associate director of Brain Tumor Immunology and Immunotherapy, are changing the way glioblastoma is treated with a next generation CAR T therapy research study. They are infusing genetically modified white blood cells directly into the fluid surrounding the brain. The second patient in the trial, Tom Fraser from upstate New York, was given just six months to live before he was introduced to the trial. It has now been almost three years since his initial diagnosis. Read more about the trial and Tom's story from New York Magazine: http://spklr.io/6040SsK6